148 related articles for article (PubMed ID: 36917124)
21. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
Kirkwood ZI; Millar BC; Downey DG; Moore JE
Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
[TBL] [Abstract][Full Text] [Related]
22. Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes.
El Ghali A; Morrisette T; Alosaimy S; Lucas K; Tupayachi-Ortiz MG; Vemula R; Wadle C; Philley JV; Mejia-Chew C; Hamad Y; Stevens RW; Zeuli JD; Webb AJ; Fiske CT; Simonyan A; Cimino CL; Mammadova M; Umana VE; Hasbun R; Butt S; Molina KC; Thomas M; Kaip EA; Bouchard J; Gore TW; Howard C; Cabanilla MG; Holger DJ; Frens JJ; Barger M; Ong A; Cohen KA; Rybak MJ
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0082423. PubMed ID: 37768312
[TBL] [Abstract][Full Text] [Related]
23.
Recchia D; Stelitano G; Stamilla A; Gutierrez DL; Degiacomi G; Chiarelli LR; Pasca MR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902066
[No Abstract] [Full Text] [Related]
24. Antimicrobial properties of basidiomycota macrofungi to
Millar BC; Nelson D; Moore RE; Rao JR; Moore JE
Int J Mycobacteriol; 2019; 8(1):93-97. PubMed ID: 30860186
[TBL] [Abstract][Full Text] [Related]
25.
Pham J; Benefield RJ; Baker N; Lindblom S; Canfield N; Gomez CA; Fisher M
Antimicrob Agents Chemother; 2024 May; 68(5):e0168623. PubMed ID: 38534103
[TBL] [Abstract][Full Text] [Related]
26. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.
Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of rifabutin against Mycobacterium abscessus, clinical isolates.
Chen J; Zhang H; Guo Q; He S; Xu L; Zhang Z; Ma J; Chu H
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):767-775. PubMed ID: 35531776
[TBL] [Abstract][Full Text] [Related]
29. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessus.
Wetzstein N; Kohl TA; Schultze TG; Andres S; Bellinghausen C; Hügel C; Kempf VAJ; Lehn A; Hogardt M; Serve H; Vehreschild MJGT; Wolf T; Niemann S; Maurer FP; Wichelhaus TA
J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32938741
[No Abstract] [Full Text] [Related]
31. A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity
Guo Q; Xu L; Tan F; Zhang Y; Fan J; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0088921. PubMed ID: 34460305
[TBL] [Abstract][Full Text] [Related]
32. Challenges and a potential solution to perform drug susceptibility testing of omadacycline against nontuberculous mycobacteria.
Shankar P; Singh S; Boorgula GD; Gumbo T; Heysell SK; Srivastava S
Tuberculosis (Edinb); 2022 Dec; 137():102269. PubMed ID: 36209660
[TBL] [Abstract][Full Text] [Related]
33. Natural Products Lysobactin and Sorangicin A Show
Sullivan JR; Yao J; Courtine C; Lupien A; Herrmann J; Müller R; Behr MA
Microbiol Spectr; 2022 Dec; 10(6):e0267222. PubMed ID: 36342177
[TBL] [Abstract][Full Text] [Related]
34. Omadacycline Potentiates Clarithromycin Activity Against
Bich Hanh BT; Quang NT; Park Y; Heo BE; Jeon S; Park JW; Jang J
Front Pharmacol; 2021; 12():790767. PubMed ID: 34955859
[No Abstract] [Full Text] [Related]
35. A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity
Wu W; He S; Li A; Guo Q; Tan Z; Liu S; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0060122. PubMed ID: 35969055
[TBL] [Abstract][Full Text] [Related]
36. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
[TBL] [Abstract][Full Text] [Related]
37. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for
Moore RE; Millar BC; Panickar JR; Moore JE
Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506
[TBL] [Abstract][Full Text] [Related]
38. "One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes.
Nguyen DC; Dousa KM; Kurz SG; Brown ST; Drusano G; Holland SM; Kreiswirth BN; Boom WH; Daley CL; Bonomo RA
Clin Infect Dis; 2021 Oct; 73(8):1532-1536. PubMed ID: 34113990
[TBL] [Abstract][Full Text] [Related]
39. AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward
Zhang S; Zou Y; Guo Q; Chen J; Xu L; Wan X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482678
[TBL] [Abstract][Full Text] [Related]
40. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
